Key clinical point: Glucagonlike peptide receptor–1 (GLP-1R) agonists may lower periostin levels in asthma.
Major finding: Counts were 30% lower in GLP-1R agonists versus non-GLP-1R agonist groups.
Study details: A retrospective evaluation of serum samples of 163 adults with asthma and type 2 diabetes.
Disclosures: Dr. Foer has no financial relationships to disclose.
Foer D et al. AAAAI Session 462, Abstract 784.